NCT06647680 2026-03-06
Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）
The Affiliated Hospital of Qingdao University
Phase 2 Recruiting
Clinical Trials
12 trialsNCT05673772 2026-02-12
SOLAR
Kyungpook National University Hospital
Phase 2 Active not recruiting
NCT05358704 2025-12-04
Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer
Rutgers, The State University of New Jersey
Phase 2 Suspended
NCT04124601 2024-04-23
CHINOREC
Medical University of Vienna
Phase 2 Completed
NCT04543695 2024-03-26
A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Active not recruiting
NCT06239870 2024-02-02
ESTIMATE
Yunnan Cancer Hospital
Phase 2 Unknown
NCT04418895 2021-11-10
Neoadjuvant Therapy for Localized Rectal Adenocarcinoma
UNC Lineberger Comprehensive Cancer Center
Phase 2 Withdrawn
NCT01037049 2018-09-17
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
Royal Marsden NHS Foundation Trust
Phase 2 Unknown
NCT03085992 2018-03-14
TRUST
Azienda Ospedaliero, Universitaria Pisana
Phase 2 Completed
NCT01507103 2017-01-13
SPRINT
Merck KGaA, Darmstadt, Germany
Phase 2 Completed
NCT00278694 2016-09-29
LARC-RRP
Oslo University Hospital
Phase 2 Completed
NCT00808379 2008-12-15
Concurrent Chemo-Radiotherapy Versus Radiotherapy With Boost in Locally Advanced Unresectable Rectal Cancers
Tata Memorial Hospital
Phase 2 Unknown